Why The FDA Cautions Rare Neurological Disease Patients About Dental Amalgams

In a press release from the FDA; the FDA has new recommendations for a common mercury-based filling, dental amalgams. While the mercury in the tooth treatment isn't significant enough to…

Continue Reading Why The FDA Cautions Rare Neurological Disease Patients About Dental Amalgams

Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19

Michael George and his team from the University of Pennsylvania have recently uncovered new insights regarding autoimmune patient’s comfortability with care during COVID-19. They've been working since the pandemic began…

Continue Reading Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19

Early Ocrelizumab Treatment Benefits Patients with Primary Progressive MS, Extension Study Shares

Did you know that there are multiple forms of multiple sclerosis (MS)? The most common form of MS is relapsing-remitting, meaning patients go through symptomatic periods and periods of remission.…

Continue Reading Early Ocrelizumab Treatment Benefits Patients with Primary Progressive MS, Extension Study Shares
A Simple Sugar Could Be the Key to Treating Multiple Sclerosis
source: pixabay.com

A Simple Sugar Could Be the Key to Treating Multiple Sclerosis

In conditions like multiple sclerosis or neuromyelitis optica, disease progression is spurred by the destruction of myelin, the protective coating around nerve cells. However, new research suggests that N-acetylglucosamine, a…

Continue Reading A Simple Sugar Could Be the Key to Treating Multiple Sclerosis
Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis
source: pixabay.com

Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis

A study reported in NewsWise evaluates retinoid-x receptor (RXR) agonists as a treatment for recurring and refractory multiple sclerosis (MS). This specific RXR agonist, bexarotene, was found to help remyelination,…

Continue Reading Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis
Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Source: Pixabay

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

  Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…

Continue Reading Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

IVX Health Opens 3 Tampa-Based Infusion Centers to Treat MS and Other Chronic Conditions

Recently, IVX Health announced the opening of three new Tampa-based infusion centers to treat patients with chronic conditions. Currently, IVX Health, who describes themselves as "[providing] biologic injections and infusions…

Continue Reading IVX Health Opens 3 Tampa-Based Infusion Centers to Treat MS and Other Chronic Conditions
Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory
source: pixabay.com

Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory

by Caitlin Seida from In The Cloud Copy Those living with autoimmune disorders like uveitis and multiple sclerosis know all too well that the cells within our bodies meant to…

Continue Reading Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory
Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases
source: pixabay.com

Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases

  According to an article in Science Alert first published in the journal The Conversation, researchers at the University of Birmingham have shown that it is possible to prevent the…

Continue Reading Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases
Close Menu